News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Vitrolife: Interim Report January-March 2008
April 28, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Strong sales and income growth * Sales increased by 19 percent to SEK 58.7 (49.2) million. Calculated in local sales currencies growth was 20 percent
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Opinion
Biotechs going to market alone must learn to go global
October 28, 2026
·
3 min read
·
Paul Bridges
Layoffs
After 2 patient deaths and cell therapy durability concerns, Artiva cuts 94% of workforce
October 27, 2026
·
2 min read
·
Angela Gabriel
Layoff Tracker
Teva closing New Jersey manufacturing facility, laying off 61 employees
October 27, 2026
·
108 min read
·
BioSpace Editorial Staff
Earnings
Novartis faces $1.9B hit from Avidity fail but maintains confidence in $12B buy
October 27, 2026
·
4 min read
·
Tristan Manalac
